The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: Implications for band 3 function

Blood

Volumn 106, Issue 13, 2005, Pages 4359-4365

  Perrotta, Silverio ^a,b   Borriello, Adriana ^b   Scaloni, Andrea ^b   De Franceschi, Lucia ^b   Brunati, Anna Maria ^b   Turrini, Francesco ^b   Nigro, Vincenzo ^b   Miraglia Del Giudice, Emanuele ^b   Nobili, Bruno ^b   Conte, Maria Luisa ^b   Rossi, Francesca ^b   Iolascon, Achille ^b   Donella Deana, Arianna ^b   Zappia, Vincenzo ^b   Poggi, Vincenzo ^b   Anong, William ^b   Low, Philip ^b   Mohandas, Narla ^b   Della Ragione, Fulvio ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE BAND 3 PROTEIN; FRUCTOSE BISPHOSPHATE ALDOLASE; MUTANT PROTEIN;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANEMIA; ARTICLE; CASE REPORT; CELL INVASION; CONTROLLED STUDY; ENZYME BINDING; ERYTHROCYTE; HUMAN; HUMAN CELL; INTRON; MALE; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

EID: 28844493639     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-07-2806     Document Type: Article

References (50)

1. Tanner MJA. The structure and function of band 3 (AE1): recent developments. Mol Membr Biol. 1997;14:155-165.
2. Tanner MJA. Band 3 anion exchanger and its involvement in erythrocyte and kidney disorders. Curr Opin Hematol. 2002;9:133-139.
3. Schofield AE, Martin PG, Spillet D, Tanner MJA. The structure of the human red blood cell anion exchanger (EPB3, AE1, band 3) gene. Blood. 1994;84:2000-2012.
4. Alper SL, Natale J, Gluck S, Lodish HF, Brown D. Subtypes of intercalated cells in rat kidney collecting duct defined by antibodies against erythroid band 3 and renal vacuolar H+-ATPase. Proc Natl Acad Sci U S A. 1989;86:5429-5433.
5. Brosius FC III, Alper SL, Garcia AM, Lodish HF. The major kidney band 3 transcript predicts an aminoterminal truncated band 3 polypeptide. J Biol Chem. 1989;264:7784-7787.
6. Kopito RR, Lodish HF. Primary structure and transmembrane orientation of the murine anion exchange protein. Nature. 1985;316:234-238.
7. Gallagher PG, Lux SE. Disorders of the erythrocyte membrane. In: Nathan DG, Orkin SH, Ginsburg D, Look AT, eds. Nathan & Oski's Hematology of Infancy and Childhood. Philadelphia, PA: WB Saunders; 2003:560-684.
8. Zhang D, Kiyatkin A, Bolin JT, Low PS. Crystallographic structure and functional interpretation of the cytoplasmic domain of erythrocyte membrane band 3. Blood. 2000;96:2925-2933.
9. Zhang Y, Manning LR, Falcone J, Platt O, Manning JM. Human erythrocyte membrane band 3 protein influences hemoglobin cooperativity: possible effect on oxygen transport. J Biol Chem. 2003;278:39565-39571.
10. Sterling D, Reithmeier RA, Casey JR. A transport metabolon: functional interaction of carbonic anhydrase II and chloride/bicarbonate exchangers. J Biol Chem. 2001;276:47886-47894.
11. Brunati AM, Bordin L, Clari G, et al. Sequential phosphorylation of protein band 3 by Syk and Lyn tyrosine kinases in intact human erytrocytes: identification of primary and secondary phosphorylation sites. Blood. 2000;96:1550-1557.
12. Chang SH, Low PS. Identification of a critical ankyrin-binding loop on the cytoplasmic domain of erythrocyte membrane band 3 by crystal structure analysis and site-directed mutagenesis. J Biol Chem. 2003;278:6879-6884.
13. Weber RE, Voelter W, Fago A, Echner H, Campanella E, Low PS. Modulation of red cell glycolysis: interactions between vertebrate hemoglobins and cytoplasmic domains of band 3 red cell membrane proteins. Am J Physiol Regul Integr Comp Physiol. 2004;287:R454-R464.
14. Bruce LJ, Beckmann R, Ribeiro ML, et al. A band 3-based macrocomplex of integral and peripheral proteins in the red cell membrane. Blood. 2003;101:4180-4188.
15. Peters LL, Shivdasani RA, Liu SC, et al. Anion exchanger 1 (band 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton. Cell. 1996;86:917-927.
16. Southgate CD, Chishti AH, Mitchell B, Yi SJ, Palek J. Target disruption of murine eythroid band 3 gene results in spherocytosis and severe haemolytic anaemia despite a normal membrane skeleton. Nat Genet. 1996;14:227-230.
17. Inaba M, Yawata A, Koshino I, et al. Defective anion transport and marked spherocytosis with membrane instability caused by hereditary total deficiency of red cell band 3 in cattle due to a nonsense mutation. J Clin Invest. 1996;97:1804-1817.
18. Hassoun H, Wang Y, Vassiliadis J, et al. Targeted inactivation of murine band 3 (AE1) gene produces a hypercoagulable state causing widespread thrombosis in vivo. Blood. 1998;92:1785-1792.
19. Hassoun H, Hanada T, Lutchman M, et al. Complete deficiency of glicophorin A in red blood cells from mice with targeted inactivation of the band 3 (AE1) gene. Blood. 1998;91:2146-2151.
20. Ribeiro ML, Alloisio N, Almeida H, et al. Severe hereditary spherocytosis and distal renal tubular acidosis associated with the total absence of band 3. Blood. 2000;96:1602-1604.
21. Miraglia del Giudice E, Vallier A, Maillet P, et al. Novel band 3 variants (bands 3 Foggia, Napoli I and Napoli II) associated with hereditary spherocytosis and band 3 deficiency: status of the D38A polymorphism within the EPB3 locus. Br J Haematol. 1997;96:70-76.
22. Perrotta S, Polito F, Conte ML, et al. Hereditary spherocytosis due to a novel frameshift mutation in AE1 cytoplasmic COOH terminal tail: band 3 Vesuvio. Blood. 1999;93:2131-2132.
23. Willardson BM, Thevenin BJ, Harrison ML, Kuster WM, Benson MD, Low PS. Localization of the ankyrin-binding site on erythrocyte membrane protein, band 3. J Biol Chem. 1989;264:15893-15899.
24. Della Ragione F, Russo GL, Oliva A, et al. 5′-deoxy-5′- methylthioadenosine phosphorylase and p16INK4 deficiency in multiple tumor cell lines. Oncogene. 1995;10:827-833.
25. Della Ragione F, Russo GL, Oliva A, et al. Biochemical characterization of p16INK4- and p18-containing complexes in human cell lines. J Biol Chem. 1996;271:15942-15949.
26. Della Ragione F, Cucciolla V, Criniti V, Indaco S, Borriello A, Zappia V. p21Cip1 gene expression is modulated by Egr1: a novel regulatory mechanism involved in the resveratrol antiproliferative effect. J Biol Chem. 2003;278:23360-23368.
27. Dodge JT, Mitchell C, Hanathan D. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys. 1963;101:119-130.
28. Lowry OH, Rosenburg NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-269.
29. Faibanks G, Steck TI, Wallach DFH. Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry. 1971;10:2606-2617.
30. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-687.
31. Miraglia del Giudice E, Iolascon A, Pinto L, Nobili B, Perrotta S. Erythrocyte membrane protein alterations underlying clinical heterogeneity in hereditary spherocytosis. Br J Haematol. 1994;88:52-55.
32. Mannu F, Arese P, Cappellini MD, et al. Role of hemichrome binding to erythrocyte membrane in the generation of band 3 alterations in beta thalassemia intermedia erythrocytes. Blood. 1995;86:2014-2020.
33. Jennings LK, Brown LK, Dockter ME. Quantitation of protein 3 content of circulating erythrocytes at the single-cell level. Blood. 1985;65:1256-1262.
34. Harlow E, Lane D. Antibodies: A Laboratory Manual. New York, NY: Cold Spring Harbor Laboratory Press; 1998.
35. Allegrini S, Scaloni A, Ferrara L, et al. Bovine cytosolic 5′-nucleotidase acts through the formation of an aspartate 52-phosphoenzyme intermediate. J Biol Chem. 2001;276:33526-33532.
36. De Franceschi L, Olivieri O, Miraglia del Giudice E, et al. Membrane cation and anion transport activities in erythrocytes of hereditary spherocytosis: effects of different membrane protein defects. Am J Hematol. 1997;55:121-128.
37. Bordin L, Brunati AM, Donella-Deana A, Baggio B, Toninello A, Clari G. Band 3 is an anchor protein and target for SHP-2 tyrosine phosphatase in human erythrocytes. Blood. 2002;100:276-282.
38. Cappadoro M, Giribaldi G, O'Brien E, et al. Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. Blood. 1998;92:2527-2534.
39. Bordin L, Clari G, Moro I, Dalla Vecchia F, Moret V. Functional link between phosphorylation state of membrane proteins and morphological changes of human erythrocytes. Biochem Biophys Res Commun. 1995;213:249-257.
40. Clark MR, Mohandas N, Shohet SB. Osmotic gradient ektacytometry: comprehensive characterization of red cell volume and surface maintenance. Blood. 1983;61:899-910.
41. Eisenmesser EZ, Post CB. Insights into tyrosine phosphorylation control of protein-protein association from the NMR structure of a band 3 peptide inhibitor bound to glyceraldehyde-3-phosphate dehydrogenase. Biochemistry. 1998;37:867-877.
42. Schneider ML, Post CB. Solution structure of a band 3 peptide inhibitor bound to aldolase: a proposed mechanism for regulating binding by tyrosine phosphorylation. Biochemistry. 1995;34:16574-16584.
43. Low PS, Allen DP, Zioncheck TF, et al. Tyrosine phosphorylation of band 3 inhibits peripheral protein binding. J Biol Chem. 1987;262:4592-4596.
44. Li X, Chen H, Oo TH, Daly TM, et al. A co-ligand complex anchors Plasmodium falciparum merozoites to the erythrocyte invasion receptor band 3. J Biol Chem. 2004;279:5765-5771.
45. Ast G. How did alternative splicing evolve? Nat Rev Genet. 2004;5:773-782.
46. Jarolim P, Rubin HL, Liu SC, et al. Duplication of 10 nucleotides in the erythroid band 3 (AE1) gene in a kindred with hereditary spherocytosis and band 3 protein deficiency (band 3 PRAGUE). J Clin Invest. 1994;93:121-130.
47. Jarolim P, Murray JL, Rubin HL, et al. Characterization of 13 novel band 3 gene defects in hereditary spherocytosis with band 3 deficiency. Blood. 1996;88:4366-4374.
48. Campanella ME, Chu H, Low PS. Assembly and regulation of a glycolytic enzyme complex on the human erythrocyte membrane. Proc Natl Acad Sci U S A. 2005;102:2402-2407.
49. Bruce LJ, Ghosh S, King MJ, et al. Absence of CD47 in protein 4.2-deficient hereditary spherocytosis in man: an interaction between the Rh complex and the band 3 complex. Blood. 2002;100:1878-1885.
50. Rybicki AC, Musto S, Schwartz RS. Identification of a band-3 binding site near the N-terminus of erythrocyte membrane protein 4.2. Biochem J. 1995;309:677-681.